ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

303
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bullishWuxi Biologics
16 Jul 2020 10:21

Wuxi Biologics - Recap/Learnings from past Placements

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
473 Views
Share
02 Jul 2020 00:03

Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing

Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...

Logo
356 Views
Share
bullishWuxi Biologics
29 Jun 2020 18:42

Wuxi Biologics Placement - This Time It's Different

Wuxi Biologics (Cayman) Inc (2269 HK) is looking to raise around US$660m in a primary placement. This is in contrast to the nine other placement...

Logo
453 Views
Share
29 Jun 2020 16:29

Asia Short Interest Weekly - Big Jump in Japan Shorts

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
293 Views
Share
bullishSamsung C&T
15 Jun 2020 06:26

Korea Synthetic Stubs: C&T at 2-Yr Low, Pure Stub Trade with Biologics

Out of the five synthetic stubs in Korea, two names are in a severe diversion at this point.They are Samsung C&T and CJ Corp.C&T is now at...

Logo
277 Views
Share
x